Obesity surgery in patients with end-stage organ failure: Is it worth it?

被引:2
|
作者
Billeter, Adrian T. [1 ]
Zumkeller, Michael [1 ]
Brock, Judith [2 ,3 ]
Herth, Felix [2 ,3 ]
Zech, Ulrike [4 ]
Zeier, Martin [5 ]
Rupp, Christian [6 ]
Wagenlechner, Petra [7 ]
Mehrabi, Arianeb [1 ]
Mueller-Stich, Beat P. [1 ]
机构
[1] Heidelberg Univ Hosp, Dept Gen Visceral & Transplant Surg, Neuenheimer Feld 420, D-69120 Heidelberg, Germany
[2] Heidelberg Univ Hosp, Thoraxklin, Dept Pneumol & Crit Care Med, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Translat Lung Res Ctr Heidelberg TLRCH, Heidelberg, Germany
[4] Heidelberg Univ Hosp, Dept Endocrinol & Metab, Heidelberg, Germany
[5] Heidelberg Univ Hosp, Dept Nephrol, Heidelberg, Germany
[6] Heidelberg Univ Hosp, Dept Gastroenterol Infect Dis & Intoxicat, Heidelberg, Germany
[7] Heidelberg Univ Hosp, Dept Gen Internal & Psychosomat Med, Heidelberg, Germany
关键词
Organ failure; High-risk; Obesity surgery; Metabolic surgery; VENTRICULAR EJECTION FRACTION; QUALITY-OF-LIFE; BARIATRIC SURGERY; SLEEVE GASTRECTOMY; HEART-FAILURE; OUTCOMES; MORTALITY; RISK; COMPLICATIONS; ASSOCIATION;
D O I
10.1016/j.soard.2021.11.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Little is known about the long-term outcomes of patients with end-stage organ failure (ESOF) undergoing obesity surgery. Objective: To investigate the perioperative and mid-term outcomes of patients with ESOF undergoing obesity surgery. Setting: University hospital, Germany. Methods: A total of 1 094 patients undergoing obesity surgery from 2006 to 2019 were screened. Inclusion criteria were ejection fraction <30%, continuous oxygen/noninvasive ventilation therapy, liver cirrhosis, or kidney failure stage 4/5. ESOF patients were compared with matched standard (MS) patients without advanced organ failure and matched for age, gender, body mass index (BMI), operation type, diabetes, arterial hypertension, and sleep apnea. Results: Twenty-seven ESOF patients (56% female, age 50.3 +/- 8.6, BMI 53.8 +/- 8.7 kg/m(2)) were identified. Eighty-five percent had a sleeve gastrectomy. Mid-term total weight loss was 26.6% +/- 9.0% in the ESOF patients versus 17.8% +/- 11.1% in MS patients (P = .181). Long-term improvement of type 2 diabetes was comparable (ESOF: HbA1C 8.79 +/- 2.06% to 6.25 +/- 1.17%, P = .047; MS: HbA1C 7.94 +/- 2.02% to 7.2 +/- 1.28%; P = .343). Depression scores (Patient Health Questionnaire 9) among ESOF patients improved from 13.0 +/- 6.3 to 6.1 +/- 5.8 (P = .004) but without significant change in MS patients (9.4 +/- 7.3 to 4.3 +/- 5.7; P = .082). Lung function improved in all patients although only 15% were off oxygen therapy. Treatment goals were achieved in >50% of the other groups. Major complications occurred in 11% (ESOF) versus 4% (MS) of patients (P = .299) with one death in the ESOF group (4%). Conclusion: Both groups had similar outcomes regarding weight loss and co-morbidity improvement. Depression only improved significantly in the ESOF group. Patients with ESOF should not be precluded from obesity surgery. Further investigation is needed to define optimized selection criteria. (C) 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:495 / 503
页数:9
相关论文
共 50 条
  • [2] OBESITY SURGERY IN PATIENTS WITH END-STAGE ORGAN FAILURE Pre and post transplantation and bariatric surgery
    Billeter, A.
    Zumkeller, M.
    Brock, J.
    Herth, F.
    Rupp, C.
    Zeier, M.
    OBESITY SURGERY, 2022, 32 (SUPPL 2) : 384 - 384
  • [3] Bariatric Surgery and End-Stage Organ Failure
    Tariq, Nabil
    Moore, Linda W.
    Sherman, Vadim
    SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (06) : 1359 - +
  • [4] Obesity in patients with end-stage heart failure
    Krol, Bogumila
    Oprzedkiewicz, Aleksandra
    Szczurek, Wioletta
    Szygula-Jurkiewicz, Bozena
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2018, 15 (03): : 176 - 179
  • [5] Cardiac surgery in patients with end-stage renal failure
    Christiansen, S
    Claus, M
    Philipp, T
    Reidemeister, JC
    CLINICAL NEPHROLOGY, 1997, 48 (04) : 246 - 252
  • [6] Cardiac surgery in end-stage renal failure patients
    Sirch, J
    Weyand, M
    Pfeiffer, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (05) : 1105 - 1106
  • [7] Bariatric surgery in patients with obesity and end-stage renal disease
    Khajeh, Elias
    Aminizadeh, Ehsan
    Moghadam, Arash Dooghaie
    Sabetkish, Nastaran
    Dezfouli, Sepehr Abbasi
    Morath, Christian
    Zeier, Martin
    Nickel, Felix
    Billeter, Adrian T.
    Mueller-Stich, Beat Peter
    Mehrabi, Arianeb
    SURGERY FOR OBESITY AND RELATED DISEASES, 2023, 19 (08) : 858 - 871
  • [8] A comprehensive approach to end-stage organ failure
    Mallick, N
    TRANSPLANTATION '96 - MAXIMIZING PATIENT BENEFIT IN TRANSPLANTATION, 1996, (217): : 133 - 137
  • [9] Cardiac surgery in end-stage renal failure patients - Reply
    Braden, GL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (05) : 1106 - 1106
  • [10] CARDIOVASCULAR SURGERY IN END-STAGE RENAL FAILURE
    LANSING, AM
    LEB, DE
    BERMAN, LB
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 204 (08): : 682 - &